Impedimed Ltd (OTCPK:IPDQF)
$ 0.048 0 (0%) Market Cap: 70.20 Mil Enterprise Value: 54.36 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 0/100

Q2 2023 ImpediMed Ltd Activities Report Call Transcript

Jan 29, 2023 / 11:30PM GMT
Operator

Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results Conference Call of Q2 FY23. (Operator Instructions)

I would now like to hand the conference over to Mr. Mike Bassett, Chief Commercial Officer. Please go ahead.

Michael John Bassett
ImpediMed Limited - Chief Commercial Officer

Thank you for joining us today. We are hosting this conference call to discuss our 4C for the financial quarter ending 31 December, 2022. I'm Mike Bassett, Chief Commercial Officer. Joining us on the call today is Rick Valencia, the new Managing Director and CEO of ImpediMed; Tim Cruickshank, our Chief Financial Officer; and Don Williams, Chair of the Board of ImpediMed.

We'll be referring to the 4C and speaking from the quarterly activity report we launched this morning, Australian time. This presentation is a summary of a more detailed 4C. After our remarks, we'll be taking questions.

Before I turn over to Don, I'd first like to bring to your attention the requisite disclaimer page that I recommend to you.

Now I'd

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot